Evaluation of Japanese encephalitis virus vaccine strains currently used in pigs by molecular characterization
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Japanese encephalitis virus (JEV) is one of the main causes of viral encephalitis in human and animals. For over 30 years, a live attenuated JEV vaccine strain has been used in the veterinary field, and it is required to conduct quality evaluation studies on the commercial vaccines. For the quality control of live attenuated JEV vaccine, we investigated the nucleotide sequence similarity of prME gene derived from five JEV vaccines commercially available in pigs in Korea. The Vero cells infected with JEV vaccines showed specific cytopathic effect, which was characterized by rounding and detached cells. In the phylogenetic analysis, all of the vaccine strains showed a close relationship with the original vaccine seed strain (Anyang 300) and clustered into the genotype 3. In comparison of the nucleotide and deduced amino acid sequences of prME genes with the original strain, all JEV vaccine strains showed high amino acid similarity ranging from 98.9% to 99.5%, but had several point mutations, probably due to high mutation rates of viral RNA polymerase by several virus passages. Even though the current JEV vaccine strains have been maintained and produced for a long period of time, the genetic characterization of them have been rarely changed. However, since the mid 1990’s, molecular epidemiology of JEV has been changed sharply from genotype 3 to genotype 1 in Korea, further studies on new vaccine strains to genotype 1 is required for more effective prevention in the field.
Abstract
Japanese encephalitis virus (JEV) is one of the main causes of viral encephalitis in human and animals. For over 30 years, a live attenuated JEV vaccine strain has been used in the veterinary field, and it is required to conduct quality evaluation studies on the commercial vaccines. For the quality control of live attenuated JEV vaccine, we investigated the nucleotide sequence similarity of prME gene derived from five JEV vaccines commercially available in pigs in Korea. The Vero cells infected with JEV vaccines showed specific cytopathic effect, which was characterized by rounding and detached cells. In the phylogenetic analysis, all of the vaccine strains showed a close relationship with the original vaccine seed strain (Anyang 300) and clustered into the genotype 3. In comparison of the nucleotide and deduced amino acid sequences of prME genes with the original strain, all JEV vaccine strains showed high amino acid similarity ranging from 98.9% to 99.5%, but had several point mutations, probably due to high mutation rates of viral RNA polymerase by several virus passages. Even though the current JEV vaccine strains have been maintained and produced for a long period of time, the genetic characterization of them have been rarely changed. However, since the mid 1990’s, molecular epidemiology of JEV has been changed sharply from genotype 3 to genotype 1 in Korea, further studies on new vaccine strains to genotype 1 is required for more effective prevention in the field.
참고문헌 (19)
- Beasley DW., "Current use and development of vaccines for Japanese encephalitis", Expert Opin Biol Ther, 8, pp.95~106 (2008)
- Campbell GL., "Estimated global incidence of Japanese encephalitis: a systematic review", Bull World Health Organ, 89, pp.766~774 (2011)
- Deng X., "Characterization of nonstructural protein 3 of a neurovirulent Japanese encephalitis virus strain isolated from a pig", Virol J, 8, pp.209~ (2011)
- Ghosh D., "Japanese encephalitis-a pathological and clinical perspective", PLoS Negl Trop Dis, 3, pp.437~ (2009)
- Baldev R. Gulati, "Isolation and genetic characterization of Japanese encephalitis virus from equines in India", Journal of Veterinary Science, 13(2), pp.111~118 (2012), 대한수의학회
- Hong SP., "Growth characteristics of an attenuated Japaneseencephalitis virus in a monkey kidney cell(Vero)", Korean J Biotechnol Bioeng, 13, pp.231~237 (1998)
- Nitatpattana N., "Change in Japanese encephalitis virus distribution, Thailand", Emerg Infect Dis, 14, pp.1762~1765 (2008)
- Nitayaphan S., "Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2", Virology, 177, pp.541~552 (1990)
- Solomon T., "Control of Japanese encephalitis-within our grasp?", N Engl J Med, 355, pp.869~871 (2006)
- Solomon T., "Origin and evolution of Japanese encephalitis virus in southeast Asia", J Virol, 77, pp.3091~3098 (2003)
- Steinhauer DA., "Rapid evolution of RNA viruses", Annu Rev Microbiol, 41, pp.409~433 (1987)
- Sumiyoshi H., "Complete nucleotide sequence of the Japanese encephalitis virus genome RNA", Virology, 161, pp.497~510 (1987)
- Uchil PD., "Phylogenetic analysis of Japanese encephalitis virus: envelope gene based analysis reveals a fifth genotype, geographic clustering, and multiple introductions of the virus into the Indian subcontinent", Am J Trop Med Hyg, 65, pp.242~251 (2001)
- Unni SK., "Japanese encephalitis virus: from genome toinfectome", Microbes Infect, 13, pp.312~321 (2011)
- Dong Kun Yang, "Molecular characterization of full-length genome of Japanese encephalitis virus(KV1899) isolated from pigs in Korea", Journal of Veterinary Science, 5(3), pp.197~205 (2004), 대한수의학회
- Dong-Kun Yang, "Immunogenicity of baculovirus expressed recombinant proteins of Japanese encephalitis virus in mice", Journal of Veterinary Science, 6(2), pp.125~133 (2005), 대한수의학회
- Yun SM, "Molecular epidemiology of Japanese encephalitis virus circulating in South Korea, 1983-2005", Virol J, 7, pp.127~ (2005)
- Wang L., "Identification and isolation of genotype-1 Japanese encephalitis virus from encephalitis patients", Virol J, 7, pp.345~ (2010)
- Zhang Y., "Mutation of putative N-linked glycosylation sites in Japanese encephalitis virus premembrane and envelope proteins enhances humoral immunity in BALB", C mice after DNA vaccination, 2011, pp.8, 138~